Main programme

>> Saturday >> Sunday >> Monday >> Tuesday >> Wednesday >> Thursday




Monday 28 June 2021

09:30 - 10:00
Coffee discussion: Sperm DNA tests: technical approaches and clinical significance
Mina Mincheva, United Kingdom
Usha R. Punjabi, Belgium
Sandro Esteves, Brazil

13:00 - 14:00
Lunch Break

16:30 - 17:00
Coffee break

08:30 - 09:30
Session 01: Keynote session
Chairs
Cristina Magli, Italy
Cornelis Lambalk, The Netherlands
08:30 - 09:00
Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve
Phillip Romanski, U.S.A.
09:00 - 09:30
Expanding the ovary’s reproductive lifespan: Preservation and Rejuvenation
Antonio Pellicer, Italy

10:00 - 11:30
Session 02: Safety follow-up on ART children; data from infant to young adult
Chairs
Zdravka Veleva, Finland
Patricia Fauque, France
10:00 - 10:15
Markers of cardiometabolic health of adolescents conceived through assisted reproductive technologies (ART) appear reassuring
Laura Wijs, Australia
10:15 - 10:30
Perinatal outcomes of infants conceived using partner versus donor sperm - An analysis of singleton and twin pregnancies from the UK national dataset
Christopher Allen, United Kingdom
10:30 - 10:45
No methylome differences observed in IVF children born after embryo culture in different culture media
Rebekka Koeck, The Netherlands
10:45 - 11:00
The association between high birth weight and long-term outcomes-implications for Assisted Reproductive Technologies: a systematic review and meta-analysis
Åsa Magnusson, Sweden
11:00 - 11:15
Neurodevelopmental morbidity in children born after ART: a Nordic register study from the Committee of Nordic ART and Safety (CoNARTaS) group
Kristiina Rönö, Finland
11:15 - 11:30
Cancer risk in a nationwide cohort of children and young adults conceived by assisted reproductive technology in 1983-2012
Mandy Spaan, The Netherlands

11:45 - 12:45
Session 06: Frontiers in human embryology
Chairs
Thomas Ebner, Austria
Kersti Lundin, Sweden
11:45 - 12:15
The puzzling unknowns of abnormal fertilization and first cleavage
Catherine Racowsky, France
12:15 - 12:45
Self-correction in human preimplantation development: What do we know?
Alison Campbell, United Kingdom

14:00 - 14:30
Session 09: Data reporting session
Chairs
Edith Coonen, The Netherlands
Antonio Capalbo
14:00 - 14:30
Data from the ESHRE PGT consortium – year 2019
Aafke Van Montfoort, The Netherlands

15:15 - 16:30
Session 13: Safety and quality of ART therapies poster discussions
Alessandra Alteri, Italy
Samuel Santos-Ribeiro, Portugal
15:15 - 15:30
Immediate versus postponed frozen-thawed embryo transfer after IVF/ICSI: a systematic review and meta-analysis
Sara Bergenheim, Denmark
15:30 - 15:45
Neurodevelopment in fetuses conceived by assisted reproductive technologies following fresh and frozen embryo transfer
María Laura Boutet, Spain
15:45 - 16:00
Cumulative live birth rate after IVF - trend over time and the impact of blastocyst culture and vitrification
Zoha Saket, Sweden
16:00 - 16:15
Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration.
Roberta Maggiulli, Italy
16:15 - 16:30
Comparison of GnRH-a trigger and GnRH-a plus low-dose HCG trigger for high ovarian responders in IVF/ICSI: A retrospective study based on propensity score matching
Ya Li, China

17:00 - 18:00
Session 17: The oocyte - the leading lady in female fertility preservation
Chairs
Maria Jose De Los Santos, Spain
Aisling Ahlstrom, Sweden
17:00 - 17:30
How effective is oocyte cryopreservation?
Ana Cobo, Spain
17:30 - 18:00
How do genes impact?
Ron Van Golde, The Netherlands

10:00 - 11:15
Session 03: Molecular advances in Reproductive Endocrinology
Chairs
Frank J. Broekmans, The Netherlands
Julia Bosdou, Greece
10:00 - 10:15
Predictive factors of autologous Oocyte Post-warming Survival rate
Debbie Montjean, France
10:15 - 10:30
Could ovarian reserve be affected after SARS-CoV-2 infection?
Maria Cruz Palomino, Spain
10:30 - 10:45
Activated AKT/mTOR signalling in peripheral blood of women with premature ovarian insufficiency and its correlation with variable FMR1 expression profiles
Julia Rehnitz, Germany
10:45 - 11:00
High variability of molecular isoforms of AMH in follicular fluid and granulosa cells from human small antral follicles
Linn Salto Mamsen, Denmark
11:00 - 11:15
The ratio AMH/antral follicle count varies according to the etiologies of diminished ovarian reserve suggesting differences in follicular health
Michaël Grynberg, France

11:45 - 12:45
Session 07: Exchange session - IFS/ISAR: Mullerian anomalies & ART
Chairs
Narendra Malhotra, India
Neena Malhotra, India
11:45 - 12:00
Mullerian anomalies overview
Sudha Prasad, India
12:00 - 12:15
Diagnosis debate – USG vs endoscopy
Kuldeep Jain, India
12:15 - 12:30
Do Mullerian anomalies need surgical correction
Prakash Trivedi, India
12:30 - 12:45
Improving outcomes in women with Mullerian anomalies
Jaideep Malhotra, India

14:00 - 15:00
Session 10: Looking beyond the xx factor
Chairs
Ashok Agarwal, U.S.A.
Csilla Gabriella Krausz, Italy
14:00 - 14:30
The significance of male factor and sperm damage to the offspring
Jackson Kirkman-Brown, United Kingdom
14:30 - 15:00
You are what your father ate- epigenetic implications
Adelheid Soubry, Belgium

15:15 - 16:30
Session 14: Reproductive endocrinology poster discussions
Dinka Pavicic Baldani, Croatia
15:15 - 15:30
Embryo euploidy rates following follicular or luteal start ovarian stimulation. A prospective study with repeated ovarian stimulation ovarian stimulation cycles.
Francisca Martinez, Spain
15:30 - 15:45
Pregnancy outcomes in women with panhypopituitarism - A population-based study.
Michael Dahan, Canada
15:45 - 16:00
Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive techniques
Isabelle Streuli, Switzerland
16:00 - 16:15
Will the hCG trigger dose used for final oocyte maturation in IVF impact endogenous progesterone during the luteal phase? - A randomized controlled trial
Louise Svenstrup, Denmark
16:15 - 16:30
Is Euploid blastocyst number higher in luteal versus follicular phase? A case-control study of IVF outcomes of follicular versus luteal phase ovarian stimulation
Beatriz Biscaro, Brazil

17:00 - 18:00
Session 18: Patient empowerment during MAR procedures
Chairs
Eline Dancet, Belgium
Klaudija Kordic, Croatia
17:00 - 17:30
Hypnofertility for reducing stress and increasing fertility preparedness
Merlinda Aluş Tokat, Turkey
17:30 - 18:00
Appeased embryo transfer with hypnosis
Daniele Lelaidier, France

10:00 - 11:30
Session 04: Morphological evaluation for euploidy detection
Chairs
Gemma Arroyo Cardona, Spain
Thomas Freour, France
10:00 - 10:15
Non-invasive, label-free optical analysis to detect aneuploidy within the inner cell mass of the preimplantation embryo
Cheow Yuen (Tiffany) Tan, Australia
10:15 - 10:30
Computer vision can distinguish between euploid and aneuploid embryos. A novel artificial intelligence (AI) approach to measure cell division activity associated with chromosomal status.
Lorena Bori, Spain
10:30 - 10:45
In-depth analysis of embryo development: Differences among monosomic, trisomic and chromosomally chaotic embryos compared to euploid embryos.
Fernando Meseguer Estornell, Spain
10:45 - 11:00
End-to-end deep learning for recognition of ploidy status using time-lapse videos
Mark Liu, Taiwan R.O.C.
11:00 - 11:15
Embryos with higher mitochondrial DNA ratios show better clinical outcomes in single euploid embryo transfer
Duke Chen, Taiwan R.O.C.
11:15 - 11:30
Performance of a commercial artificial intelligence software for embryo selection (Embryoscope/KIDScore™) on predicting biopsied and non-biopsied blastocyst clinical pregnancy according to score subgroups.
Renata Erberelli, Brazil

11:45 - 12:45
Session 08: Ethics of ART: of embryos, oocyte donors and RCTs
Chairs
Heidi Mertes, Belgium
Jacky Boivin, United Kingdom
11:45 - 12:00
Is the process to retract fabricated randomised clinical trials in reproductive medicine working sufficiently?
Ben W. Mol, Australia
12:00 - 12:15
The ethics of stem cell-based embryo-like structures: a focus group study on the attitudes of Dutch professionals and lay citizens
Ana Pereira Daoud, The Netherlands
12:15 - 12:30
The presentation of medical risks and incentives in egg donation: an analysis of Belgian, Spanish and UK fertility clinic websites
Veerle Provoost, Belgium
12:30 - 12:45
Embryo selection using Artificial Intelligence (AI): Epistemic and ethical considerations
Michael Afnan, United Kingdom

14:00 - 15:00
Session 11: Reproductive epidemiology, socio-cultural aspects and health economy poster discussions
Jaime Onofre Meza, Belgium
14:00 - 14:15
Paternal smoking in the preconception period is associated with an increased risk of spontaneous miscarriage in a dose-dependent manner: a systematic review and meta-analysis
Nadia du Fossé, The Netherlands
14:15 - 14:30
Self-declared infertility and child desire among women of reproductive age in the National Survey of Demography and Health, Brazil
Sandra Garcia, Brazil
14:30 - 14:45
Socio-cultural and clinical implications of ‘routine’ AMH testing in India: Insights from an interview study with the healthcare professionals (HCPs)
Priya Satalkar, Belgium
14:45 - 15:00
Elevated levels of ambient air pollutants increase the primary sex ratio in human embryos
Mariangela Maluf, Brazil

15:15 - 16:30
Session 15:Reproductive (epi)genetics poster discussions
Efthymia Constantinou, Cyprus
15:30 - 15:45
Validation of a Next Generation Sequencing (NGS) workflow integrating simultaneous analysis of ploidy, microdeletions and de novo monogenic diseases for expanded preimplantation genetic testing (PGT).
Silvia Caroselli, Italy
15:15 - 15:30
NAT10-mediated N4-acetylcytidine in RNA regulates mouse oocyte maturation in vitro
Yuting Xiang, China
15:45 - 16:00
Whole-chromosome aneuploidies revealed by transcriptome of trophectoderm biopsied from human pre-implantation blastocyst.
Li Song, China
16:00 - 16:15
Analysis of segregation patterns of trivalent structure and the effect on genome stability in Robertsonian translocation carriers
Tongyuan Dang, China
16:15 - 16:30
What trophectoderm cells from mosaic embryos tell us about embryonic competence at the transcriptional level
Angel Martin, Spain

17:00 - 18:00
Session 19: Exchange session- ASRM: COVID and Endometriosis: two inflammatory diseases with multi-organ effects.
Chairs
Carlos Calhaz-Jorge, Portugal
Michael A. Thomas, U.S.A.
17:00 - 17:30
Endometriosis is a Systemic disease
Hugh Taylor, U.S.A.
17:30 - 18:00
COVID – Impact on reproduction and reproductive practice
Marcelle Cedars, U.S.A.

10:00 - 11:30
Session 05: Genetic Analyses in Andrology
Chairs
Liliana Ramos, The Netherlands
Nathalie Rives, France
10:00 - 10:15
A Genome Wide Association Study in men with unexplained infertility identifies nine SNPs at the FSHB locus to be associated with Follicle Stimulating Hormone level
Maria Schubert, Germany
10:15 - 10:30
Correcting a PLCζ mutation in the human germ line to overcome hereditary infertility
Bieke Bekaert, Belgium
10:30 - 10:45
Semen microbiota in patients with astenozoospermia and healthy controls: cluster analysis of real-time PCR data
Evgenia Panacheva, Russia C.I.S.
10:45 - 11:00
Sperm phenotype, ICSI outcome and genetic diagnosis in case of severe asthenozoospermia with multiple morphological abnormalities of the flagellum
Lucile Ferreux, France
11:00 - 11:15
Male translocations in recurrent pregnancy loss: Natural conception versus PGD treatment: what is the right option?: A systematic review and meta-analysis.
Daniella Cardenas Armas, United Kingdom
11:15 - 11:30
Utilization of ultrastructural analysis and genomics of spermatozoa to better characterize subtle forms of male factor infertility
Kolbe Hancock, U.S.A.

14:00 - 15:00
Session 12: Recurrent implantation failure: A multi disciplinary approach
Chairs
Bettina Toth, Austria
Roy G Farquharson, United Kingdom
14:00 - 14:30
Diagnostic strategies
Nicholas Macklon, United Kingdom
14:30 - 15:00
Therapeutic aspects
Dinka Pavicic Baldani, Croatia

15:15 - 16:30
Session 16: Psychology and counselling poster discussions
Verena Ehrbar, Switzerland
15:15 - 15:30
Are FET and IUI cycles less emotionally difficult for patients than IVF? Evidence from smartphone app based emotional tracking data
Isla Robertson, United Kingdom
15:30 - 15:45
Recurrent pregnancy loss acts as a posttraumatic stress event in both women and men
Emily Kuhlmann, Germany
15:45 - 16:00
Focus groups with health care professionals, patient advocates and patients to explore how the potential need for multiple cycles is managed during fertility treatment consultations
China Harrison, United Kingdom
16:00 - 16:15
A randomised controlled trial comparing expectant management or intrauterine-insemination in couples with unexplained subfertility and a poor prognosis for natural conception: the impact on health-related-quality-of-life
Femke Mol, The Netherlands
16:15 - 16:30
Analysis of the extent of dropout-rates by extraction from cumulative live birth rates in IVF/ICSI: systematic review and meta-analysis
Sofie Vereeck, Belgium

17:00 - 18:00
Session 20: Novel technologies in reproduction
Chairs
Mina Popovic, Spain
Susana M. Chuva de Sousa Lopes, The Netherlands
17:00 - 17:15
TEAD4 regulates trophectoderm differentiation upstream of CDX2 in human preimplantation embryos
Panagiotis Stamatiadis, Belgium
17:15 - 17:30
Generation of artificial oocytes by two distinct mechanisms
Philip Xie, U.S.A.
17:30 - 17:45
Neospermatogenesis benefits from a three-dimensional culture system
Sherina Lawrence, U.S.A.
17:45 - 18:00
Polymeric scaffold loaded with CD133+ BMDSCs for endometrial regeneration in Asherman’s syndrome
Nandakumar Venkatesan, Spain

18:15 - 18:45
ESHRE Quiz
Roger Sturmey, United Kingdom

09:30 - 10:15
IBSA INSTITUT BIOCHIMIQUE SA: The future of endometrial preparation: challenges and opportunities
The future of endometrial preparation: challenges and opportunities
Chair
Nicholas Macklon, United Kingdom
09:30 - 09:35
Welcome and introduction
Nicholas Macklon, United Kingdom
09:35 - 09:50
New challenges of the ‘freeze-all’ era?
Annalisa Racca, Spain
09:50 - 10:05
Tomorrow’s perspectives for endometrial preparation
Dominique De Ziegler, France
10:05 - 10:15
Live Q&A

11:30 - 12:15
ORGANON LLC : The new generation in Ovarian Stimulation
The new generation in ovarian stimulation
Chair
Juan A. Garcia-Velasco, Spain
11:30 - 11:45
A brief history of Organon
Barbara Stegmann, U.S.A.
11:45 - 12:00
Is there a need to measure progesterone in the late Follicular Phase?
Georg Griesinger, Germany
12:00 - 12:15
Optimising Fresh Embryo Transfers in Ovarian Stimulation
Human Mousavi Fatemi, United Arab Emirates

13:00 - 14:00
COOPERSURGICAL: Demystifying mosaicism: Notable Key Opinion Leaders discussing the transfer potential of embryos with mosaic results and the recent mosaic outcome data publication
Chair
Tony Gordon, United Kingdom
Panel discussion: Demystifying mosaicism: Notable Key Opinion Leaders discussing the transfer potential of embryos with mosaic results and the recent mosaic outcome data publication
Santiago Munne, Spain
Manuel Viotti, U.S.A.
Tony Gordon, United Kingdom
Mark R. Hughes, U.S.A.

15:00 - 15:45
BESINS HEALTHCARE Global :Is it Worth to Monitor Progesteron Blood Levels (P4) in ART Cycles?
Is it Worth to Monitor Progesteron Blood Levels (P4) in ART Cycles?
Chair
Klaus Diedrich, Germany
15:00 - 15:05
Introduction
Klaus Diedrich, Germany
15:05 - 15:20
How to personalize luteal phase support by measuring P4 in ART cycles
Elena Labarta, Spain
15:20 - 15:35
What clinicians should know when measuring P4 in ART
Peter Platteau, Belgium
15:35 - 15:45
Q & A
Klaus Diedrich, Germany

16:30 - 17:15
VITROLIFE: Breaking new ground in embryo evaluation; unlocking the toolbox
Breaking new ground in embryo evaluation; unlocking the toolbox
Chair
David K. Gardner, Australia
16:30 - 16:35
Introduction
David K. Gardner, Australia
16:35 - 16:55
Past, present and future of time lapse in clinical IVF
Markus Montag, Germany
16:55 - 17:15
Advances in preimplantation genetic testing for aneuploidy for embryo selection
Kathryn Gebhardt, Australia

18:00 - 19:00
GEDEON RICHTER: A multidisciplinary update on endometriosis and infertility
A multidisciplinary update on endometriosis and Infertility
Chair
Herman Tournaye, Belgium
18:00 - 18:15
The effect of endometriosis on the oocyte and endometrium
Paola Vigano, Italy
18:15 - 18:45
Clinical management of advanced endometriosis related infertility
Tommaso Falcone, U.S.A.
18:45 - 19:00
Fertility preservation strategies in endometriosis
Pietro Santulli, France
closing remarks
Herman Tournaye, Belgium

09:45 - 10:30
ABBOTT: Meeting patient needs in luteal phase support and endometriosis
Meeting patient needs in luteal phase support and endometriosis
Chair
Jan I. Olofsson, Switzerland
09:45 - 09:50
Welcome and introductions
Jan I. Olofsson, Switzerland
09:50 - 10:05
Lotus program and beyond
Herman Tournaye, Belgium
10:05 - 10:20
Infertility in endometriosis
Svetlana Dubrovina, Russia C.I.S.
10:20 - 10:30
Discussion / closing

12:15 - 13:00
FERRING: Making data matter: Parting the clouds in clinical practice
Making data matter: parting the clouds in clinical practice
Chair
12:15 - 12:20
Introduction
12:20 - 12:28
Leveraging AMH to expand access to individualised treatment
Antonio La Marca, Italy
12:28 - 12:36
Expanding scientific knowledge to address ethnic diversities
Jie Qiao, China
12:36 - 12:44
Harnessing the power of individual patient data: a meta-analysis
Femi Janse, The Netherlands
12:44 - 12:52
How much does a live birth cost? HEOR analysis of the MEGASET-HR trial
Jared Robins, U.S.A.
12:52 - 13:00
Adding convenience to the power of HP-hMG
Michael D. Scheiber, U.S.A.

16:45 - 17:30
FUJIFILM IRVINE SCIENTIFIC: Leading the way in IVF through innovative solutions
Leading the way in IVF through innovative solutions
Chair
Robert Newman, U.S.A.
16:45 - 16:55
Innovation station – What's on the horizon for IVF?
Nadir H. Ciray, U.S.A.
16:55 - 17:20
What’s good for the egg is good for the outcome
Matthew VerMilyea, U.S.A.
17:20 - 17:30
Q&A